CPhI Worldwide has revealed the finding from part i of its fifth edition of the CPhI Annual Report, which show the trend towards the integration of pharmaceutical outsourcing continues but the rate of change remains unclear.
In this instalment, we find out about the life, loves and career drivers of the new director of Regulatory Affairs and QP Services at Wasdell, Colin Newbould.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a response to the recently published study in the British Medical Journal (BMJ) on the efficacy of cancer medicines, noting the importance of real-world data.
PatSnap, a provider of research and development (R&D) analytics, has launched an online learning hub that will provide users with free courses on intellectual property (IP), PatSnap Academy.
Scientists at the University of Washington (UW) have designed mini-protein binders on a computer platform, which are not naturally occurring and may potentially be possible drug candidates.
Edison Investment Research, has released an independent and detailed analyst report into T-cell cancer therapies, highlighting the potential and limitations of current CAR-T approaches for most tumour types.
New data, released by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence, has revealed that the venture capital funding and secondary offerings in the biotech sector are on track to beat last year’s figures
A survey performed onsite at CPhI Korea has highlighted that domestic companies are anticipating a headline growth in the order of 16% across the South Korean pharma market.
In this article Vasiliki Nikolaou and David M. Haddleton from Medherant, The Venture Centre University of Warwick Science Park, detail transdermal drug delivery, a non-invasive option that has the potential to improve patient adherence.
